Clinical Trials Browser

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT07005024 2026-02-05

DOAC

Phase 3 Recruiting

996 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT05683808 2026-01-30

VTE-POG

Phase 2 Recruiting

40 enrolled

CNSClassical hematology

Astrocytoma, Glioblastoma, Glioma, Venous Thromboembolism

NCT07270263 2025-12-26

HEM-DOAC

Phase NA Recruiting

100 enrolled

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Pulmonary Embolism, Hematologic Neoplasms, Venous Thromboembolism

NCT07189897 2025-10-08

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

Phase 4 Recruiting

76 enrolled

Classical hematologyHead & Neck

Head and Neck Neoplasms, Thrombosis, Venous Thromboembolism

NCT06474182 2025-09-25

ProApix

Phase NA Recruiting

32 enrolled

Plasma cell

Multiple Myeloma

NCT07132515 2025-08-20

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

Phase 4 Recruiting

100 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT06603870 2025-05-30

STREAM-Line

Phase 4 Recruiting

330 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism, Catheter-Related Infections, Upper Extremity Deep Vein Thrombosis

NCT06284343 2024-09-19

GynCAT

Recruiting

1,800 enrolled

Classical hematologyGynecologic

Uterine Cervical Neoplasms, Neoplasms, Ovarian Neoplasms, Thrombosis, Vaginal Neoplasms, Endometrial Neoplasms, Venous Thromboembolism

Clinical Trials

Apixaban in Thrombocytopenia

DOAC

VTE-POG

HEM-DOAC

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

ProApix

Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC

STREAM-Line

GynCAT